Brain Ischemia in Alzheimer's Disease May Partly Counteract the Disruption of the Blood-Brain Barrier

被引:1
作者
Bateman, Grant A. [1 ,2 ]
Bateman, Alexander R. [3 ]
机构
[1] John Hunter Hosp, Dept Med Imaging, Newcastle, NSW 2310, Australia
[2] Newcastle Univ, Coll Hlth Med & Wellbeing, Sch Med & Publ Hlth, Callaghan Campus, Newcastle, NSW 2308, Australia
[3] Newcastle Univ, Coll Engn Sci & Environm, Sch Engn, Callaghan Campus, Newcastle, NSW 2308, Australia
关键词
Alzheimer's disease; blood-brain barrier; cerebral blood flow; CSF formation rate; glymphatic; ischemia; normal pressure hydrocephalus; NORMAL-PRESSURE HYDROCEPHALUS; MILD COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; CEREBRAL PERFUSION; VENOUS-PRESSURE; FLOW; PATHOGENESIS; METABOLISM; PHYSIOLOGY; HUMANS;
D O I
10.3390/brainsci15030269
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: In normal pressure hydrocephalus (NPH) there is blood-brain barrier (BBB) disruption, which should increase the CSF formation rate (CSFfr) and, therefore, also increase the intracranial pressure (ICP). However, the ICP is normal in NPH. A lumped parameter study was performed to look at the interrelation between the ICP, cerebral blood flow (CBF), and the degree of BBB disruption in NPH. The model suggested that the CSFfr could be reduced in this condition if the BBB disruption was moderated by a reduction in the capillary transmural pressure (TMP) secondary to arteriolar constriction and a reduced CBF. In early Alzheimer's disease (AD), there is BBB disruption, reduced ICP, and global ischemia. This raises the possibility that the same physiology may occur in AD as occurs in NPH. Methods: A lumped parameter model previously used to describe the hydrodynamics of NPH was modified to investigate the effects of changes in CSF pressure and blood flow in patients with mild cognitive impairment (MCI) and AD. Results: The model indicates that the average capillary TMP is normal in MCI, but decreases as AD progresses. Removing CSF in AD patients during a tap test initially increases the capillary TMP. The brain in AD responds to a tap test by increasing its level of ischemia, and this reduces the capillary TMP. Conclusions: A hypothesis is put forward that the BBB disruption in AD is partially mitigated by the brain making itself ischemic. Modelling gives support to this hypothesis. The model can suggest a cause for the development of ischemic neuronal loss and amyloid accumulation secondary to glymphatic flow disruption as AD progresses.
引用
收藏
页数:16
相关论文
共 50 条
[31]   Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier [J].
Takeuchi, Lily E. ;
V. Kalia, Lorraine ;
Simmons, Craig A. .
NEUROBIOLOGY OF DISEASE, 2025, 208
[32]   Disruption of blood brain barrier in Alzheimer disease pathogenesis [J].
Kook, Sun-Young ;
Hong, Hyun Seok ;
Moon, Minho ;
Mook-Jung, Inhee .
TISSUE BARRIERS, 2013, 1 (02)
[33]   How Alpha Linolenic Acid May Sustain Blood-Brain Barrier Integrity and Boost Brain Resilience against Alzheimer's Disease [J].
Leikin-Frenkel, Alicia ;
Schnaider Beeri, Michal ;
Cooper, Itzik .
NUTRIENTS, 2022, 14 (23)
[34]   A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain [J].
Ryu, Jae K. ;
McLarnon, James G. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (9A) :2911-2925
[35]   Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device [J].
Epelbaum, Stephane ;
Burgos, Ninon ;
Canney, Michael ;
Matthews, Dawn ;
Houot, Marion ;
Santin, Mathieu D. ;
Desseaux, Carole ;
Bouchoux, Guillaume ;
Stroer, Sebastian ;
Martin, Cyril ;
Habert, Marie-Odile ;
Levy, Marcel ;
Bah, Aicha ;
Martin, Karine ;
Delatour, Benoit ;
Riche, Maximilien ;
Dubois, Bruno ;
Belin, Lisa ;
Carpentier, Alexandre .
ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
[36]   Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer’s disease with an implantable ultrasound device [J].
Stéphane Epelbaum ;
Ninon Burgos ;
Michael Canney ;
Dawn Matthews ;
Marion Houot ;
Mathieu D. Santin ;
Carole Desseaux ;
Guillaume Bouchoux ;
Sebastian Stroer ;
Cyril Martin ;
Marie-Odile Habert ;
Marcel Levy ;
Aicha Bah ;
Karine Martin ;
Benoît Delatour ;
Maximilien Riche ;
Bruno Dubois ;
Lisa Belin ;
Alexandre Carpentier .
Alzheimer's Research & Therapy, 14
[37]   Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease [J].
Yue, Qian ;
Hoi, Maggie Pui Man .
NEURAL REGENERATION RESEARCH, 2023, 18 (09) :1890-1902
[38]   Alzheimer's disease: future drug development and the blood-brain barrier [J].
Pardridge, William M. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) :569-572
[39]   Alzheimer's disease drug development and the problem of the blood-brain barrier [J].
Pardridge, William A. .
ALZHEIMERS & DEMENTIA, 2009, 5 (05) :427-432
[40]   Epigenetics in blood-brain barrier disruption [J].
Ihezie, Stephanie A. ;
Mathew, Iny Elizebeth ;
McBride, Devin W. ;
Dienel, Ari ;
Blackburn, Spiros L. ;
Thankamani Pandit, Peeyush Kumar .
FLUIDS AND BARRIERS OF THE CNS, 2021, 18 (01)